Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
Clinical trial NCT02071329 · COMPLETED
Trial details
- NCT number
- NCT02071329
- Sponsor
- Immune Targeting Systems Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2014-12-01
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.